Development and Testing of Novel Interventions to Improve HIV Prevention, Treatment, and Program Implementation for People Who Use Substances (R34 Clinical Trial Required)
Closed Posted
- Opportunity number
- PAR-24-329
- Agency
-
National Institutes of Health
Department of Health and Human Services
- Applications due
- Award size
- Not on record
Opportunity facts
- Assistance listings
- Funding instrument
- Grant
- Categories
-
- Education
- Health
- Eligible applicants
-
- Tribal Organizations (Not Federally Recognized)
- Tribal Governments (Federally Recognized)
- Small Businesses
- State Governments
- Independent School Districts
- 501(c)(3) Nonprofits
- Other
- City/Township Governments
- Higher Education Inst. (Private)
- Higher Education Inst. (Public)
- County Governments
- Non-501(c)(3) Nonprofits
- Special District Governments
- For Profit Organizations
- Public or Indian Housing Auth.
- Points of contact
-
- NIH OER Webmaster grantsinfo@nih.gov
- Full announcement
Opportunity details come from Grants.gov. Updated .
About this opportunity
NIH has expired early, effective immediately under NOT-OD-26-029, its grant opportunity for developing and testing novel HIV prevention, treatment, and program implementation interventions for people who use substances (R34 Clinical Trial Required), which carried a due date of October 27, 2026. The most recent update converted the close date to align with that notice and expired the NOFO.
Eligibility is broad. Tribal governments (federally recognized and not federally recognized), state, county, city/township, and special district governments, independent school districts, public or Indian housing authorities, public and private higher education institutions, 501(c)(3) and non-501(c)(3) nonprofits, small businesses, for-profit organizations, and "Other" applicants qualify. Listed other eligible applicants include Alaska Native and Native Hawaiian Serving Institutions, AANAPISIs, eligible federal agencies, faith-based or community-based organizations, Hispanic-serving institutions, HBCUs, TCCUs, regional organizations, non-domestic (non-U.S.) entities, and U.S. territories or possessions.
The program supports formative research, intervention development, and pilot-testing. Primary focus areas are the feasibility, tolerability, acceptability, and safety of novel or adapted interventions targeting HIV prevention, treatment, or services research for people who use drugs. Eligible interventions may be behavioral, social, or structural, or combination biomedical and behavioral approaches that prevent HIV acquisition and transmission or improve clinical outcomes for people living with HIV.
Support is recommended for a specified project period, usually not in excess of 5 years. Review considers scientific and technical merit, feasibility of the research, potential contribution to the national drug abuse problem, and relevance to NIDA priorities. The source does not assign weights to these considerations.
The opportunity falls under Assistance Listing 93.279, Drug Use and Addiction Research Programs, and is categorized under Education and Health. The attached Application Guide for FORMS-I and the full announcement, PAR-24-329, were posted January 8, 2025.
Synopsis
2 versions
Update #2 · Latest ·
This notice of funding opportunity (NOFO) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention, treatment or services research for people who use drugs. For the purposes of this NOFO, "intervention" may include behavioral, social, or structural approaches, as well as combination biomedical and behavioral approaches that prevent the acquisition and transmission of HIV infection, or improve clinical outcomes for persons living with HIV.
Update #1 ·
This notice of funding opportunity (NOFO) encourages formative research, intervention development, and pilot-testing of interventions. Primary scientific areas of focus include the feasibility, tolerability, acceptability and safety of novel or adapted interventions that target HIV prevention, treatment or services research for people who use drugs. For the purposes of this NOFO, "intervention" may include behavioral, social, or structural approaches, as well as combination biomedical and behavioral approaches that prevent the acquisition and transmission of HIV infection, or improve clinical outcomes for persons living with HIV.
Eligibility
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession.
Files
| File | Type | Posted |
|---|---|---|
| PAR-24-329-Full-Announcement.html | HTML file | |
| PKG00289974.pdf |
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar grant opportunities
- Ask GovTribe AI about this opportunity